VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 17, 2006) - WEX Pharmaceuticals Inc. (“WEX” or the “Company”) (TSX:WXI) today announced that it is reducing its workforce in North America by more than 50% for an expected cost saving of approximately $1,000,000 per year in direct salaries and related costs. The Company will also be taking additional measures to extend its financial resources to allow for the continued development of its lead product candidate TectinTM.
